Mereo BioPharma Group plc Annual Operating Income (Loss) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mereo BioPharma Group plc quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
  • Mereo BioPharma Group plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.8M, a 1480% decline year-over-year.
  • Mereo BioPharma Group plc annual Operating Income (Loss) for 2023 was -$28.4M, a 47.8% increase from 2022.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$28.4M +$26M +47.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$54.4M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.